fme US, LLC’s Post

I'm excited to attend again one of the most important conferences in this space. It's not just a great conference but also a family reunion of sorts. Are you planning RIM improvements for 2025? If not, you should be. Advances in RIM strategies and technology can save you substantial time and money while reducing your regulatory risks. fme can help you evaluate your current system, decide if a newer solution matches your needs, and correctly classify your data, documents, and metadata for optimal performance and efficiency. As a perfect continuation of my Monday Musings posts, we’ll discuss this in Booth #315 this year. Learn more below and join us! I look forward to seeing you! #RSIDM25 #Regulatory #LifeSciences #datamigration

Planning RIM improvements for 2025? If not, you should be. Advances in RIM strategies and technology can save you substantial time and money while reducing your regulatory risks. fme can help you evaluate your current system, decide if a newer solution matches your needs, and correctly classify your data, documents, and metadata for optimal performance and efficiency. This is what we’ll be discussing at Regulatory Submissions, Information, and Document Management Forum in Booth #315 this year. Learn more below and join us! #RSIDM25 #Regulatory #LifeSciences #datamigration

Planning RIM improvements for 2025? If not, you should be. Advances in RIM strategies and technology can save you substantial time and money while reducing your regulatory risks. fme can help you evaluate your current system, decide if a newer solution matches your needs, and correctly classify your data, documents, and metadata for optimal performance and efficiency. This is what we’ll be discussing at Regulatory Submissions, Information, and Document Management Forum in Booth #315 this year. Learn more below and join us! #RSIDM25 #Regulatory #LifeSciences #datamigration

The #HDATraceability24 event brought the pharmaceutical industry together to discuss #DSCSA progress. Catch up on what you missed with Christiane’s insights from the seminar! HDA - Healthcare Distribution Alliance #OCI #Pharma #SupplyChain #Credentialing #Compliance

🧐 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝗵𝗼𝘄 𝗱𝗮𝘁𝗮-𝗱𝗿𝗶𝘃𝗲𝗻 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆? 🧬 In today's #interestingread, we dive into an article from European Biopharmaceutical Review, featuring our cutting-edge Bio|Verse framework. This customizable platform enables biotech companies to harness complex data for actionable insights, accelerating drug development while navigating economic challenges. 💡 Read the full article here to learn how Bio|Verse is revolutionizing drug discovery: https://lnkd.in/dU7vk5Fk #Bioinformatics #AIinBiotech #DrugDiscovery #DataDrivenScience #PrecisionMedicine

I enjoyed a recent panel discussion on the future of generics and biosimilars at the recent Medicines for Europe Annual conference in Dublin. Some interesting points came through, especially from Rebecca Guntern, Sandoz CCO and Stephan Eder, EVP Western Europe & Germany at STADA: In short - the industry has all the data it needs to address the challenges we face. What’s needed now is immediate action—especially when it comes to pricing reform and regulatory changes. Pricing structure that incorporates factors such as security of supply, quality, and environmental impact, rather than solely focusing on cost reduction An holistic view must be sought: The need to view healthcare system in its entirety, and the fact that the pharmaceutical sector, whilst a significant factor, cannot shoulder all the cost-cutting pressures alone. This, combined with the importance of collaboration among pharmaceutical companies, even competitors, to share resources, co-develop products, and streamline procurement and distribution...   Listen to the complete webinar here: https://lnkd.in/ePY_pMKk    

What if data from clinical research flowed seamlessly from the protocol to the site to the sponsor's data collection to submission? The steps to get there include digitizing the protocol. Please join HL7 Vulcan, CDISC and TransCelerate BioPharma Inc. in the collaboration to digitize the protocol by joining this webinar to learn more. Register: https://lnkd.in/ekBKxNC4

Make sure to check out this Twist Bioscience webinar if you are interested in EU IVDR regulation and how it will affect labs. Learn more about the new Twist Precision Dx products! https://lnkd.in/eEfSkniG

Diving into Analytical #QbD is all about strengthening your Analytical Target Profile and making drug development more efficient 🚀 Check out our Industry Insight for a handy roadmap to help you along the way 👉 https://lnkd.in/dBB3tvyz

Attending #SCOPESummit this month? Attend this session by Calyx's Lee Bardy and learn how advanced #IRT can help manage expected and emergency drug shortages, enabling you to plan, design, and adapt as your trial needs change. https://lnkd.in/gu5JJH9s #RTSM #ClinicalTrials #ChooseCalyx #Randomization #TrialSupplyManagement